Piero Ferollà

4.3k total citations · 1 hit paper
42 papers, 1.8k citations indexed

About

Piero Ferollà is a scholar working on Epidemiology, Oncology and Neurology. According to data from OpenAlex, Piero Ferollà has authored 42 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Epidemiology, 28 papers in Oncology and 23 papers in Neurology. Recurrent topics in Piero Ferollà's work include Neuroendocrine Tumor Research Advances (36 papers), Lung Cancer Research Studies (25 papers) and Neuroblastoma Research and Treatments (22 papers). Piero Ferollà is often cited by papers focused on Neuroendocrine Tumor Research Advances (36 papers), Lung Cancer Research Studies (25 papers) and Neuroblastoma Research and Treatments (22 papers). Piero Ferollà collaborates with scholars based in Italy, France and United States. Piero Ferollà's co-authors include Diego Ferone, Wouter W. de Herder, Philippe Ruszniewski, Anders Sundín, Babs G. Taal, John Ramage, Wolfgang Weber, Andreas Pascher, Gianfranco Delle Fave and Tetsuhide Ito and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Annals of Oncology.

In The Last Decade

Piero Ferollà

42 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms

2016 330 citations Piero Ferollà, Diego Ferone et al. Neuroendocrinology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Piero Ferollà Italy	20	1.5k	1.3k	963	205	183	42	1.8k
Staffan Welin Sweden	21	2.4k 1.6×	2.2k 1.6×	1.7k 1.7×	130 0.6×	165 0.9×	67	2.7k
Anthony Chan United Kingdom	11	1.5k 1.0×	1.5k 1.1×	887 0.9×	158 0.8×	49 0.3×	22	1.7k
M. Wied Germany	9	2.3k 1.6×	2.1k 1.6×	1.8k 1.9×	56 0.3×	141 0.8×	13	2.4k
Letizia Boninsegna Italy	25	2.3k 1.6×	2.3k 1.7×	1.4k 1.4×	62 0.3×	25 0.1×	31	2.5k
Alison Langley United Kingdom	5	1.4k 1.0×	1.3k 1.0×	1.1k 1.2×	27 0.1×	97 0.5×	12	1.5k
Anna Sowa‐Staszczak Poland	16	685 0.5×	555 0.4×	444 0.5×	73 0.4×	151 0.8×	70	970
Séverine Martinez France	4	1.4k 0.9×	1.3k 1.0×	1.1k 1.1×	24 0.1×	95 0.5×	6	1.5k
Laura Catena Italy	17	628 0.4×	764 0.6×	459 0.5×	100 0.5×	54 0.3×	48	1.0k
Anna Malczewska Poland	19	749 0.5×	704 0.5×	410 0.4×	39 0.2×	36 0.2×	37	902
Guillermo Crespo Spain	14	526 0.4×	709 0.5×	362 0.4×	127 0.6×	62 0.3×	33	1.0k

Countries citing papers authored by Piero Ferollà

Since Specialization

Citations

This map shows the geographic impact of Piero Ferollà's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piero Ferollà with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piero Ferollà more than expected).

Fields of papers citing papers by Piero Ferollà

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piero Ferollà. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piero Ferollà. The network helps show where Piero Ferollà may publish in the future.

Co-authorship network of co-authors of Piero Ferollà

This figure shows the co-authorship network connecting the top 25 collaborators of Piero Ferollà. A scholar is included among the top collaborators of Piero Ferollà based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piero Ferollà. Piero Ferollà is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Malandrino, Pasqualino, Tiziana Feola, Sergio Di Molfetta, et al.. (2024). Radioligand Therapy in Patients with Lung Neuroendocrine Tumors: A Systematic Review on Efficacy and Safety. Seminars in Nuclear Medicine. 54(4). 570–580. 3 indexed citations

Ferollà, Piero, Alfredo Berruti, Francesca Spada, et al.. (2022). Efficacy and Safety of Lanreotide Autogel and Temozolomide Combination Therapy in Progressive Thoracic Neuroendocrine Tumors (Carcinoid): Results from the Phase 2 ATLANT Study. Neuroendocrinology. 113(3). 332–342. 16 indexed citations

Baudin, Éric, Martyn Caplin, Rocio García‐Carbonero, et al.. (2021). Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆. Annals of Oncology. 32(4). 439–451. 139 indexed citations

Arato, Iva, Francesca Mancuso, Catia Bellucci, et al.. (2021). Effect of EPA on Neonatal Pig Sertoli Cells “In Vitro”: A Possible Treatment to Help Maintain Fertility in Pre-Pubertal Boys Undergoing Treatment With Gonado-Toxic Therapies. Frontiers in Endocrinology. 12. 694796–694796. 8 indexed citations

Ferollà, Piero, Alfredo Berruti, Francesca Spada, et al.. (2020). 1161MO Lanreotide autogel (LAN) and temozolomide (TMZ) combination therapy in progressive thoracic neuroendocrine tumours (TNETs): ATLANT study results. Annals of Oncology. 31. S773–S773. 9 indexed citations

Faggiano, Antongiulio, Roberta Modica, Luigi Camera, et al.. (2018). The antiproliferative effect of pasireotide LAR alone and in combination with everolimus in patients with medullary thyroid cancer: a single-center, open-label, phase II, proof-of-concept study. Endocrine. 62(1). 46–56. 16 indexed citations

Ferollà, Piero, Tim Meyer, Wasat Mansoor, et al.. (2016). Efficacy and safety of pasireotide LAR or everolimus alone, or in combination in patients with advanced carcinoids (NET) of the lung/thymus: Results from the randomized, phase 2 LUNA study. Annals of Oncology. 27. vi136–vi136. 28 indexed citations

Campana, Davide, D. Ravizza, Piero Ferollà, et al.. (2016). Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study. Endocrine. 56(3). 633–638. 30 indexed citations

Ricciuti, Biagio, Giulio Metro, Piero Ferollà, et al.. (2015). Clinical outcome of platinum/etoposide treated large cell neuroendocrine carcinomas of the lung according to the type of radiotherapy received: a single institution analysis. Annals of Oncology. 26. vi78–vi78. 2 indexed citations

10.

Campana, Davide, D. Ravizza, Piero Ferollà, et al.. (2015). Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study. Endocrine. 51(1). 131–139. 35 indexed citations

11.

Ferollà, Piero. (2015). Medical Therapy of Pulmonary Neuroendocrine Neoplasms: Targeted, Symptomatic and Chemotherapy. Frontiers of hormone research. 44. 193–197. 6 indexed citations

12.

Ferollà, Piero. (2014). Medical Treatment of Advanced Thoracic Neuroendocrine Tumors. Thoracic surgery clinics/Thorac. surg. clin.. 24(3). 351–355. 13 indexed citations

13.

Moretti, Patrizia, et al.. (2013). Comorbilità di ansia e depressione nei pazienti con tumori carcinoidi. Rivista di psichiatria. 48(4). 301–6. 5 indexed citations

14.

Faggiano, Antongiulio, Valeria Ramundo, Alessandra Dicitore, et al.. (2011). Everolimus is an active agent in medullary thyroid cancer: a clinical and in vitro study. Journal of Cellular and Molecular Medicine. 16(7). 1563–1572. 36 indexed citations

15.

Faggiano, Antongiulio, Franco Grimaldi, Luciano Pezzullo, et al.. (2008). Secretive and proliferative tumor profile helps to select the best imaging technique to identify postoperative persistent or relapsing medullary thyroid cancer. Endocrine Related Cancer. 16(1). 225–231. 15 indexed citations

16.

Lim, Eric, Peter Goldstraw, Andrew G. Nicholson, et al.. (2008). Proceedings of the IASLC International Workshop on Advances in Pulmonary Neuroendocrine Tumors 2007. Journal of Thoracic Oncology. 3(10). 1194–1201. 58 indexed citations

17.

Ferollà, Piero, Antongiulio Faggiano, Gelsomina Mansueto, et al.. (2008). The biological characterization of neuroendocrine tumors: The role of neuroendocrine markers. Journal of Endocrinological Investigation. 31(3). 277–286. 47 indexed citations

18.

Faggiano, Antongiulio, Gelsomina Mansueto, Piero Ferollà, et al.. (2008). Diagnostic and prognostic implications of the World Health Organization classification of neuroendocrine tumors. Journal of Endocrinological Investigation. 31(3). 216–223. 32 indexed citations

19.

Ferollà, Piero, Antongiulio Faggiano, Nicola Avenia, et al.. (2006). Epidemiology of non‐gastroenteropancreatic (neuro)endocrine tumours. Clinical Endocrinology. 66(1). 1–6. 16 indexed citations

20.

Ferollà, Piero, Alberto Falchetti, Pier Luigi Filosso, et al.. (2005). Thymic Neuroendocrine Carcinoma (Carcinoid) in Multiple Endocrine Neoplasia Type 1 Syndrome: The Italian Series. The Journal of Clinical Endocrinology & Metabolism. 90(5). 2603–2609. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact